Paeoniflorin Alleviates Lipopolysaccharide-Induced Neuroinflammation and Depression Through the Keap1/Nrf2/HO-1 Signaling Pathway
Antioxidants · 13.05.2025 · 14 (5) · 585
DOI: 10.3390/antiox14050585 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 13.05.2025. Verfasst von Zhuoyue Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Northwest University, Xi'an 710069, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanxi, Shanxi Fundamental Science Research Project.
Themen: Depression
Abstract (Originalsprache)
Depression is associated with bidirectional interactions between inflammatory responses and behavioral dysfunction. Paeoniflorin (PF), a monoterpene glycoside derived from Paeonia lactiflora, exhibits potent anti-inflammatory properties. This study investigates the therapeutic effects of PF on lipopolysaccharide (LPS)-induced depression-like behaviors in mice and neuroinflammation in BV2 microglial cells. Mice were co-administered PF (20, 40, or 80 mg/kg/day) and LPS (2 mg/kg) for 7 days. Behavioral tests; Nissl staining; and Golgi, Iba1, DLG4, and cytokine assays were conducted. Additionally, hippocampal NF-κB, Nrf2, and BDNF signaling pathways were analyzed using Western blots. In BV2 cells, oxidative stress and the Nrf2/HO-1 pathway were assessed using CCK-8, flow cytometry, and Western blotting after 24 h of LPS and PF treatment. PF significantly alleviated LPS-induced depression-like behaviors, increased hippocampal neuron and dendritic spine density, and upregulated synaptic proteins (PSD95, SNAP25, and BDNF). Mechanistically, PF suppressed NLRP3 inflammasome activation via the Akt/GSK3β pathway, reduced pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6), and enhanced the Nrf2/HO-1 antioxidant axis. In BV2 cells, PF restored mitochondrial membrane potential, inhibited apoptosis, and decreased cytokine levels (TNF-α, IL-1β, and IL-6) by inhibiting TLR4/NF-κB signaling. In conclusion, PF significantly improved LPS-induced depression-like behaviors and attenuated neuroinflammation in BV2 microglial cells, highlighting its potential as a therapeutic agent for inflammation-associated depression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Northwest University, Xi'an 710069, China.
- Key Laboratory of Resource Biology and Biotechnology in Western China, Northwest University, Xi'an 710069, China.
ORCID-Profile: Yanjun Cao
Förderung
- Natural Science Foundation of Shanxi
- Shanxi Fundamental Science Research Project
Zitieren
APA
Hu, Z., Wang, X., Shi, T., Yang, L., Zhang, B., Shang, B., He, R., Yi, S., He, J., Hu, J., & Cao, Y. (2025). Paeoniflorin Alleviates Lipopolysaccharide-Induced Neuroinflammation and Depression Through the Keap1/Nrf2/HO-1 Signaling Pathway. Antioxidants, 14(5), 585. https://doi.org/10.3390/antiox14050585
Vancouver
Hu Z, Wang X, Shi T, Yang L, Zhang B, Shang B, et al. Paeoniflorin Alleviates Lipopolysaccharide-Induced Neuroinflammation and Depression Through the Keap1/Nrf2/HO-1 Signaling Pathway. Antioxidants. 2025;14(5):585. doi:10.3390/antiox14050585
BibTeX
@article{Hu2025,
author = {Hu, Zhuoyue and Wang, Xing and Shi, Tian and Yang, Lei and Zhang, Boxi and Shang, Bo and He, Ruizhi and Yi, Shichen and He, Jiao and Hu, Jing and Cao, Yanjun},
title = {Paeoniflorin Alleviates Lipopolysaccharide-Induced Neuroinflammation and Depression Through the Keap1/Nrf2/HO-1 Signaling Pathway},
journal = {Antioxidants},
year = {2025},
volume = {14},
number = {5},
pages = {585},
doi = {10.3390/antiox14050585}
}
EUVIMED